Printer Friendly

Sounding the steroids alarm.

The death of Ken Caminiti at age 41 should have sounded an alarm for every baseball, prayer and anybody else who has used illegal anabolic steroids. Caminiti used steroids heavily in 1996 when he was the National League's Most Valuable Player, and he recently tested positive for cocaine. On October 10, he collapsed, apparently of a heart attack, and died. [Experts say that steroids and cocaine use may have contributed to his death.] But for all Caminiti achieved as a third baseman for the San Diego Padres and other teams, he'll, be remembered for blowing the whistle during the 2002 season on the use of steroids by himself and others. His public confession contributed to the inclusion of steroid testing of players for the first time. With tuck, his death will read to even stricter testing.
COPYRIGHT 2004 Scholastic, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:Anderson, Dave
Publication:New York Times Upfront
Article Type:Brief Article
Geographic Code:1USA
Date:Nov 15, 2004
Previous Article:Surf's up! Hawaii may soon become the first state in the nation to recognize surfing as an official high school sport.
Next Article:In Sudan, stuck in a war zone with no way to flee.

Related Articles
They shoot horses, don't they? Anabolic steroids and their challenge to law enforcement.
Rat memory skills boosted by steroid.
Supplements & Steroids: BODY WARS!
Foul shot.
Behind the bulk: one young man's story of steroid addiction, body obsession, and getting clean. (Close-up: Steroids).
Designer steroids: ugly, dangerous things.
The incredible bulk: Major League Baseball struggles to beat performance-enhancing drugs.
Steroid trends.
Safety and efficacy of topical steroids with and without topical antibiotics.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters